✦ LIBER ✦

The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects

✍ Scribed by M. Zdravkovic; T. Christiansen; L. Eliot; H. Agersoe; M.S. Thomsen; J.F. Falch; B. Søgaard; L. Ynddal; M.M. Ilondo

Book ID: 117837082
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 256 KB
Volume: 11
Category: Article
ISSN: 1096-6374
DOI: 10.1054/ghir.2000.0188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics, pharmacodynamics,

The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers

✍ M. Zdravkovic; B. Søgaard; L. Ynddal; T. Christiansen; H. Agersø; M.S. Thomsen; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects

✍ Chi, Yong Ha; Lee, Howard; Paik, Soo Heui; Lee, Joo Han; Yoo, Byoung Wook; Kim, 📂 Article 📅 2011 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 211 KB

The pharmacokinetics, pharmacodynamics a

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

✍ Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes

✍ Heise, T.; Seewaldt-Becker, E.; Macha, S.; Hantel, S.; Pinnetti, S.; Seman, L.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

A Phase 1, dose escalation study to eval

A Phase 1, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral daily doses of ELND006 in healthy elderly subjects

✍ Liang, Earvin; Liu, Wenzhong Jerry; Lohr, Lisa; Nguyen, Van; Lin, Holly; Munson, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The safety, tolerability, pharmacokineti

The safety, tolerability, pharmacokinetics, and pharmacodynamics of a selective 5-HT2A antagonist, M100907, following single and multiple oral dosing in healthy volunteers

✍ F. Brunner; V. Bhargava; D. Howard; S.J. Offord 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 361 KB